XML 108 R94.htm IDEA: XBRL DOCUMENT v3.23.1
Reverse Recapitalization - Summary of Detailed Information About Excess Fair Value of Shares Issued Over Fair Value of Identifiable Net Assets Acquired (Detail) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 14, 2022
Dec. 31, 2022
Disclosure of Reverse Recapitalization [Line Items]    
IFRS 2 Expense on the Closing Date € 74,540  
PCAC [Member]    
Disclosure of Reverse Recapitalization [Line Items]    
Identifiable Assets Acquired Liabilities Assumed under share based payment transactions 24,661  
IFRS 2 Expense on the Closing Date 74,540 € 74,540
PCAC [Member] | LGHL ordinary shares [Member]    
Disclosure of Reverse Recapitalization [Line Items]    
Value of shares issued under share based payments transactions € 99,201